RSS Feeds
Search

Companies

Companies

Displaying 1..1 of 1 - per page
Order by
NorthShore University HealthSystem Research Institute
NorthShore University HealthSystem Research Institute More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
FDA Withdraws Approval of Avastin in Breast Cancer
Jan 2011 - 4 pages - $500
Breast Cancer Drug Discoveries: what the future holds 2008: Chapter
Dec 2008 - 200 pages - $1,390
Rectal Cancer - Pipeline Review, Q3 2011
Jul 2011 - 206 pages - $500
Iniparib Failure: Highlights the Uncertainty in Late Stage Breast Cancer Pipeline
Mar 2011 - 5 pages - $500
Avastin and the AVADO Trial Survey
Feb 2008 - $2,500
Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market
May 2011 - 7 pages - $500
Rectal Cancer Global Clinical Trials Review, Q4, 2010
Dec 2010 - 66 pages - $1,000
Spanish Breast Cancer Research Group – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
R&D Trends: Breast Cancer - Innovative approaches target key signaling pathways in breast tumors
Jul 2011 - 36 pages - $3,800
Breast Cancer Global Clinical Trials Review, Q4, 2010
Oct 2010 - 100 pages - $1,000
More Related Market Research Reports >>>

Your selection

Industry sector
Drug delivery del
Rectal del
Therapeutic target
Oncology del
Breast cancer del
Adenocarcinoma del
Geographic location
North America del

Browse By

Industry sector
Liquid
Sustained release
Tablet
Geographic location
Canada
USA

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us